Assay Detail
Binding
CHEMBL5216079
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Inhibition of recombinant human ACE2 using fluorogenic peptide substrate VI measured every 36 sec for 10 mins by fluorescence reader analysis
1
Total Activities
1
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Homo sapiens |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Publication
Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 1 | 4.24 | 4.24 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL3219078 | — | — | 1 | 4.24 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL3219078 | — | IC50 | = | 57000.0 | nM | 4.24 |